In MS, mRNA expression for CRP, IL-6, NF-κB and TNF-α showed reductions by 28.0% (p = 0.006), 7.5% (p = 0.36), 22.7% (p = 0.044) and 23.3% (p = 0.030), respectively (Fig. 3D). This evidence concerns the gene NFKB1 and myeloid sarcoma.